DOI QR코드

DOI QR Code

Characteristics of Hodgkin Lymphoma in a Defined Group of Iranian Pediatric Patients

  • Baharvand, Maryam (Department of Oral Medicine, Faculty of Dentistry, Shahid Beheshti University of Medical Sciences) ;
  • Mortazavi, Hamed (Department of Oral Medicine, Faculty of Dentistry, Shahid Beheshti University of Medical Sciences)
  • Published : 2014.07.15

Abstract

This study was conducted to describe the characteristics of Hodgkin lymphoma in Iranian children. In a referral center for pediatric oncology (Mofid Hospital) in Tehran, patient data over a 10-year period were retrieved and recorded accordingly. Among 82 cases, 73.2% were male, 26.8% were female, and 70.7% were 5-9 years old. About 40% of patients were in stage III and 42.7% had systemic signs. Cervical nodes were commonly involved (91.5%). The most frequent histological subtype was mixed cellularity. The main hematological features were anemia (47.6%), lymphopenia (20.7%), and eosinophilia (8.7%). Survival rate was 72%, and 8.4% of patients were deceased. A 3% recurrence rate was observed in our patients. A significant relationship was found between the stage of disease and systemic signs (P<0.0005, ${\chi}^2$). Despite diagnosis of Hodgkin lymphoma in many children in Iran being made in higher stages, the mortality rate is relatively low.

Keywords

References

  1. Araujo I, Bittencourt AL, Barbosa HS, et al (2006). The high frequency of EBV infection in pediatric hodgkin lymphoma is related to the classical type in Bahia, Brazil. Virchows Arch, 449, 315-9. https://doi.org/10.1007/s00428-006-0244-z
  2. Bazzeh F, Rihani R, Howard S, Sultan I (2010). Epidemiology and end results program comparing adult and pediatric hodgkin lymphoma in the surveillance, 1988-2005: an analysis of 21 734 cases. Leuk Lymphoma, 51, 2198-207. https://doi.org/10.3109/10428194.2010.525724
  3. Belgaumi A, Al-Kofide A, Joseph N, et al (2008). Hodgkin lymphoma in very young children: clinical characteristics and outcome of treatment. Leuk Lymphoma, 49, 910-6. https://doi.org/10.1080/10428190801947492
  4. Birch JM, Alston RD, Quinn M, Kelsey AM (2003). Incidence of malignant disease by morphological type, in young persons aged 12-24 years in England, 1979-1997. Eur J Cancer, 39, 2622-31. https://doi.org/10.1016/j.ejca.2003.08.006
  5. Bociek RG, Armitage JO (1999). Hodgkin's disease and non-hodgkin's lymphoma. Curr Opin Hematol, 6, 205-15. https://doi.org/10.1097/00062752-199907000-00003
  6. Burkhardt B, Zimmermann M, Oschlies I, et al (2005). The impact of age and gender on biology, clinical features and treatment outcome of non-hodgkin lymphoma in childhood and adolescence. Br J Haematol, 131, 39-49. https://doi.org/10.1111/j.1365-2141.2005.05735.x
  7. Chabay PA, Barros MH, Hassan R, et al (2008). Pediatric Hodgkin lymphoma in 2 South American series: a distinctive epidemiologic pattern and lack of association of Epstein-Barr virus with clinical outcome. J Pediatr Hematol Oncol, 30, 285-91. https://doi.org/10.1097/MPH.0b013e3181647bc3
  8. Clarke CA, Glaser SL (2002). Changing incidence of non-Hodgkin lymphomas in the United States. Cancer, 94, 2015-23. https://doi.org/10.1002/cncr.10403
  9. de Camargo B, de Oliveira Santos M, Rebelo MS, et al (2010). Cancer incidence among children and adolescents in Brazil: first report of 14 population-based cancer registries. Int J Cancer, 126, 715-20. https://doi.org/10.1002/ijc.24799
  10. Dinand V, Arya LS (2007). Hodgkin's lymphoma in Indian children: prevalence and significance of Epstein-Barr virus detection in Hodgkin's and Reed-Sternberg cells. Eur J Cancer, 43, 161-8. https://doi.org/10.1016/j.ejca.2006.08.036
  11. Dinesh K, Thulkar S, Bakhshi S, Madhusudan KS, Upadhyay AD (2011). Pediatric hodgkin lymphoma: CT features at presentation, on treatment and its prognostic significance. Indian J Pediatr, 78, 549-54. https://doi.org/10.1007/s12098-010-0342-4
  12. Ahmed HG, Elmubasher MB, Salih RA, Elhussein GE, Ashankyty IM (2013). Fine needle aspiration cytopathology of pediatric lymphadenopathy among Sudanese children. Asian Pac J Cancer Prev, 14, 4359-63. https://doi.org/10.7314/APJCP.2013.14.7.4359
  13. Glaser SL, Hsu JL (2002). Hodgkin's disease in asians: incidence patterns and risk factors in population-based data. Leuk Res, 26, 261-9. https://doi.org/10.1016/S0145-2126(01)00126-6
  14. Gualco G, Klumb CE, Barber GN, Weiss LM, Bacchi CE (2010). Pediatric lymphomas in Brazil. Clinics (Sao Paulo), 65, 1267-77. https://doi.org/10.1590/S1807-59322010001200008
  15. Harris NL (1999). Hodgkin's disease: classification and differential diagnosis. Mod Pathol, 12, 159-75.
  16. Harris NL (1999). Hodgkin's lymphomas: classification, diagnosis, and grading. Semin Hematol, 36, 220-32.
  17. Huang X, Nolte I, Gao Z, et al (2011). Epidemiology of classical hodgkin lymphoma and its association with Epstein Barr virus in Northern China. PLoS One, 6, 21152. https://doi.org/10.1371/journal.pone.0021152
  18. Jaffe ES (1999). Introduction: hodgkin's lymphoma--pathology, pathogenesis, and treatment. Semin Hematol, 36, 217-9.
  19. Jaglowski SM, Linden E, Termuhlen AM, Flynn JM (2009).Lymphoma in adolescents and young adults. Semin Oncol, 36, 381-418. https://doi.org/10.1053/j.seminoncol.2009.07.009
  20. Lee MY, Tan TD, Feng AC (2005). Clinico-pathological study of hodgkin's lymphoma in a cancer center in Taiwan. Clin Lab Haematol, 27, 379-83. https://doi.org/10.1111/j.1365-2257.2005.00736.x
  21. Linabery AM, Erhardt EB, Fonstad RK, et al (2014). Infectious, autoimmune and allergic diseases and risk of hodgkin lymphoma in children and adolescents: a children's oncology group study. Int J Cancer, 13, [Epub ahead of print]
  22. Mac Mahon B (1957). Epidemiological evidence of the nature of Hodgkin's disease. Cancer, 10, 1045-54. https://doi.org/10.1002/1097-0142(195709/10)10:5<1045::AID-CNCR2820100527>3.0.CO;2-0
  23. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  24. Riad R, Omar W, Kotb M, et al (2010). Role of PET/CT in malignant pediatric lymphoma. Eur J Nucl Med Mol Imaging, 37, 319-29 https://doi.org/10.1007/s00259-009-1276-9
  25. Song N, Han S, Lee KM, et al (2012). Genetic variants in interleukin-2 and risk of lymphoma among children in Korea. Asian Pac J Cancer Prev, 13, 621-3. https://doi.org/10.7314/APJCP.2012.13.2.621
  26. Sandoval C, Venkateswaran L, Billups C, et al (2002). Lymphocyte-predominant hodgkin disease in children. J Pediatr Hematol Oncol, 24, 269-73. https://doi.org/10.1097/00043426-200205000-00010
  27. Schwartz CL (2005). Special issues in pediatric hodgkin's disease. Eur J Haematol Suppl, 66, 55-62.
  28. Smith MA, Seibel NL, Altekruse SF, et al (2010). Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol, 28, 2625-34. https://doi.org/10.1200/JCO.2009.27.0421
  29. Srina A, Jetsrisuparb A, Komvilaisak P, Kamsaard S, Wiangnon S (2010). Trends in incidence of childhood lymphoma in Khon Kaen,Thailand, 1985-2008. Asian Pac J Cancer Prev, 11, 1683-6.
  30. Thomas RK, Re D, Zander T, Wolf J, Diehl V (2002). Epidemiology and etiology of hodgkin's lymphoma. Ann Oncol, 13, 147-52. https://doi.org/10.1093/annonc/mdf652
  31. Vassallo J, Paes RP, Soares FA, et al (2005). Histological classification of 1,025 cases of Hodgkin's lymphoma from the State of Sao Paulo, Brazil. Sao Paulo Med J, 123, 134-6. https://doi.org/10.1590/S1516-31802005000300009
  32. Wang KL, Liu CL, Zhuang Y, Qu HY (2013). Breastfeeding and the risk of childhood hodgkin lymphoma: a systematic review and meta-analysis. Asian Pac J Cancer Prev, 14, 4733-7. https://doi.org/10.7314/APJCP.2013.14.8.4733
  33. Ward E, Desantis C, Robbins A, Kohler B, Jemal A (2014). Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin, 64, 83-103. https://doi.org/10.3322/caac.21219

Cited by

  1. Treating Adults with Hodgkin Lymphoma in the Developing World: a Hospital-Based Cohort Study from Armenia vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.101
  2. Incidence of Childhood Hodgkin Lymphoma in Mexico by Histologic Subtypes and Socioeconomic Regions vol.38, pp.3, 2016, https://doi.org/10.1097/MPH.0000000000000462